Danske Bank’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Danske Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Buy	304,539 +19,600	+7%	+$653K	0.02%	452
2026 Q1	$8.58M	Buy	284,939 +12,400	+5%	+$399K	0.02%	461
2025 Q4	$8.51M	Buy	272,539 +24,400	+10%	+$601K	0.02%	471
2025 Q3	$5.01M	Sell	248,139 -12,400	-5%	-$218K	0.01%	538
2025 Q2	$4.37M	Buy	260,539 +20,900	+9%	+$337K	0.01%	545
2025 Q1	$3.68M	Sell	239,639 -2,700	-1%	-$48.2K	0.01%	580
2024 Q4	$5.34M	Buy	242,339 +22,200	+10%	+$404K	0.02%	525
2024 Q3	$3.97M	Buy	220,139 +24,800	+13%	+$434K	0.01%	582
2024 Q2	$3.17M	Buy	195,339 +3,900	+2%	+$60.1K	0.01%	591
2024 Q1	$2.7M	Buy	+191,439	New	+$2.41M	0.01%	642

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Danske Bank's TEVA Position: Q2 2026 in Review

Danske Bank increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 6.9% in Q2 2026, buying an estimated $653K and bringing the position to 304,539 shares worth $10.3M. The position accounts for 0.02% of the portfolio, ranked #452.

Danske Bank first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Danske Bank held 304,539 shares of Teva Pharmaceutical Industries Limited worth $10.3M as of Q2 2026.
Danske Bank bought 19,600 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $653K.
Teva Pharmaceutical Industries Limited made up 0.02% of Danske Bank's portfolio in Q2 2026, its #452 holding.
Danske Bank first reported a position in Teva Pharmaceutical Industries Limited in Q1 2024 and has held it in 10 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.